悦心健康(002162) - 2020 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders rose by 51.76% to CNY 29,895,788.51 for the current period[7] - Operating revenue for the current period was CNY 385,874,472.69, an increase of 11.03% year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 61.10% to CNY 30,851,077.94[7] - Basic earnings per share rose by 51.52% to CNY 0.0350[7] - Total operating revenue for Q3 2020 was CNY 385,874,472.69, an increase from CNY 347,549,996.90 in the previous period[45] - Net profit for Q3 2020 reached CNY 24,801,201.47, compared to CNY 19,446,690.42 in the same period last year, representing a growth of approximately 27.5%[47] - The net profit for the current period is ¥854,245.36, significantly lower than ¥10,195,938.84 in the previous period, reflecting a challenging market environment[51] - The net profit attributable to the parent company is ¥53,305,548.64, up from ¥34,217,985.46, indicating improved profitability[56] Assets and Liabilities - Total assets increased by 10.23% to CNY 2,579,684,756.89 compared to the end of the previous year[7] - The company's total assets decreased by 100% in trading financial assets, reflecting the redemption of all financial products during the reporting period[15] - The total liabilities increased significantly, with current liabilities due within one year rising by 475.13% to RMB 98,330,183.38, largely from financing arrangements[16] - The total liabilities increased to CNY 1,518,067,027.15 from CNY 1,347,767,676.46, representing a rise of approximately 12.6%[39] - The company's total assets amounted to CNY 2,645,244,404.70, slightly up from CNY 2,640,592,119.01[43] - Total liabilities were CNY 1,230,675,108.40, remaining stable compared to CNY 1,230,675,792.81 in the previous period[43] - The company's equity increased to CNY 1,414,569,296.30 from CNY 1,409,916,326.20, reflecting a growth of about 0.4%[43] Cash Flow - The net cash flow from operating activities increased by 104.65% to CNY 59,380,526.05[7] - Cash flow from operating activities decreased by 29.86% to RMB 49,762,386.55, primarily due to cash collection being affected by project progress[25] - The net cash flow from financing activities improved by 85.10%, amounting to a net outflow of RMB 22,340,649.11, due to increased capital contributions from minority shareholders[26] - Cash flow from operating activities generated $49.76 million, down 29.9% from $70.95 million in the previous period[63] - Cash flow from investing activities resulted in a net outflow of $57.83 million, compared to a smaller outflow of $8.84 million last year[63] - Cash inflow from financing activities increased to ¥250,813,495.95 from ¥168,589,605.52, leading to a net cash flow from financing activities of ¥34,139,541.43[67] Shareholder Information - The total number of shareholders at the end of the reporting period was 49,424[11] - CIMIC Industrial Inc. held the largest share, with a 46.83% stake, totaling 399,795,802 shares[11] Research and Development - Research and development expenses rose by 37.62% to RMB 3,284,997.15 in Q3 2020, reflecting increased investment in innovation[20] - Research and development expenses for the quarter were CNY 3,284,997.15, compared to CNY 2,386,997.43 in the same period last year, indicating an increase of approximately 37.6%[46] - Research and development expenses increased to ¥599,280.13 from ¥449,178.12, highlighting the company's commitment to innovation[49] Government Support - The company received government subsidies totaling CNY 6,437,866.01, primarily from local government support[8] Other Financial Metrics - The weighted average return on equity increased to 3.01%, up from 0.92%[7] - The company reported a significant increase in construction in progress, up 305.88% to RMB 111,521,792.66, attributed to new investments in subsidiaries[16] - The company experienced a 285.54% increase in credit impairment losses, amounting to RMB 10,958,781.39, due to changes in accounting estimates for receivables[21] - The company's interest income increased by 80.25% to RMB 461,877.46 in Q3 2020, driven by higher bank acceptance bill deposits[20] - The company reported investment income of CNY 963,942.38, down from CNY 1,887,896.42 year-over-year[46]